Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma
Clinical trial NCT02856997 · UNKNOWN
Trial details
- NCT number
- NCT02856997
- Sponsor
- Yuankai Shi
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-03-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.